ALSO NOTED: BioCryst raises $65M; FDA approves Sanctura XR; and much more...

> BioCryst Pharmaceuticals has announced a $65 million private placement. Release

> The FDA has provided its approval for Indevus' Sanctura XR, the once-daily formulation of its therapy for overactive bladder. Release

> Thrilling AIDS activists and frustrating the drug company, an Indian court rejected Novartis' challenge to its drug patent laws. FiercePharma

> Patients who once dependent on Vioxx for arthritis relief are still lobbying Merck to get the drug back on the market--despite the documented risk of heart attacks, strokes, even death. FiercePharma

And Finally… Scientists have found that even left-handedness has a genetic link. Report